Asian patients are half as likely to be started on biologic drugs for rheumatoid arthritis as white patients, new research has shown.
This article was originally published on MedicalXpress.com
Asian patients are half as likely to be started on biologic drugs for rheumatoid arthritis as white patients, new research has shown.
This article was originally published on MedicalXpress.com
© 2024 SimplyWell.ca